800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

A Study to Assess the Effects of Dexpramipexole in Participants with Eosinophilic COPD (SUSPIRE)

view all Clinical Trials

Overview

This is an open-label Phase II study assessing the PD of dexpramipexole 150 mg twice daily (BID) in participants with eosinophilic COPD. This study will help characterize the profile and duration of reductions of blood absolute eosinophil counts (AEC).

Clinical Trial Information

Protocol

TIRB#: 31883

Phase

2

Condition(s)

Chronic Obstructive Pulmonary Disease (COPD)

Investigator

Gerard Criner, MD

Coordinator

Helga Criner, Marium Rashid, Priya Walia

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

An Open-label Phase II Study to Assess the Pharmacodynamic (PD) Effects of Dexpramipexole in Participants with Eosinophilic Chronic Obstructive Pulmonary Disease (COPD)